KBC Group
IDYA icon

KBC Group’s IDEAYA Biosciences IDYA Stock Holding History

KBC Group’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$139K Hold
3,608
– – ﹤0.01% 1197
2026
Q2 		$134K Hold
3,608
– – ﹤0.01% 1236
2026
Q1 		$120K Hold
3,608
– – ﹤0.01% 1217
2025
Q4 		$125K Buy
3,608
+925
+34% +$29.5K ﹤0.01% 1143
2025
Q3 		$73K Hold
2,683
– – ﹤0.01% 1473
2025
Q2 		$56K Sell
2,683
-1,514
-36% -$29K ﹤0.01% 1555
2025
Q1 		$69K Hold
4,197
– – ﹤0.01% 1684
2024
Q4 		$108K Buy
4,197
+1,923
+85% +$54.4K ﹤0.01% 1501
2024
Q3 		$72K Buy
2,274
+513
+29% +$19.5K ﹤0.01% 1504
2024
Q2 		$62K Buy
1,761
+483
+38% +$19.1K ﹤0.01% 1485
2024
Q1 		$56K Buy
+1,278
New +$55K ﹤0.01% 1484

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return

KBC Group's IDYA Position: Q3 2026 in Review

KBC Group held its IDEAYA Biosciences (IDYA) position steady in Q3 2026 at 3,608 shares worth $139K. The position accounts for ﹤0.01% of the portfolio, ranked #1197.

KBC Group first reported a position in IDYA in Q1 2024 and has held it in 11 quarters since. 204 funds tracked by Wall St. Rank hold IDYA as of Q3 2026.

  • KBC Group held 3,608 shares of IDEAYA Biosciences worth $139K as of Q3 2026.
  • KBC Group left its IDEAYA Biosciences share count unchanged in Q3 2026.
  • IDEAYA Biosciences made up ﹤0.01% of KBC Group's portfolio in Q3 2026, its #1197 holding.
  • KBC Group first reported a position in IDEAYA Biosciences in Q1 2024 and has held it in 11 quarters since.
  • 204 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2026.

Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.